In Brief: MacroChem
This article was originally published in The Tan Sheet
Executive Summary
MacroChem: Transdermal ibuprofen product for muscle pain will enter Phase I/II trials. The topical formulation is based on the company's Soft Enhancement Percutaneous Absorption (SEPA) technology. The Lexington, Mass.-based firm says it will study about 400 people at two sites. The study will be coordinated by Essex Labs of Verona, N.J...
MacroChem: Transdermal ibuprofen product for muscle pain will enter Phase I/II trials. The topical formulation is based on the company's Soft Enhancement Percutaneous Absorption (SEPA) technology. The Lexington, Mass.-based firm says it will study about 400 people at two sites. The study will be coordinated by Essex Labs of Verona, N.J.... |